ConductScience.org, home

Paper6239683

Methods for amplifying the induction and expression of cytotoxic response in vitro to syngeneic and autologous freshly-isolated solid tumors of mice.

Kedar E and 2 others. Cancer Immunol Immunother, 1984. Cited by 13 papers, by iCite.

Cite this record

ConductScience Library. Methods for amplifying the induction and expression of cytotoxic response in vitro to syngeneic and autologous freshly-isolated solid tumors of mice. Papers, record 6239683. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6239683

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Methods for amplifying the induction and expression of cytotoxic response in vitro to syngeneic and autologous freshly-isolated solid tumors of mice.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1984
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
13
iCite
Relative citation ratio, by iCite
0.38
iCite
Revised in PubMed
2024-04-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kedar EE
2Chriqui-Zeira EE
3Mitelman SS

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytotoxicity, ImmunologicMajor topic
Leukemia, ExperimentalMajor topic
Lung NeoplasmsMajor topic
LymphocytesMajor topic
MelanomaMajor topic
Animals
DNA Replication
Interleukin-2
Lymphocyte Activation
Lymphocyte Culture Test, Mixed
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Neoplasm Transplantation
Transplantation, Autologous
Transplantation, Isogeneic

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
5R01CA31859NCI NIH HHSUnited StatesR01CA031859PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16334139Immunotherapy of murine and human tumors in mice with lymphokines and interleukin-2-propagated lymphocytes.J Biol Response Mod1984https://conductscience.org/library/papers/6334139PubMed
26194216Activation of nonspecific killer cells by interleukin 2-containing supernatants.J Immunol1983https://conductscience.org/library/papers/6194216PubMed
3314344Further characterization of suppressor lymphocytes induced by fetal calf serum in murine lymphoid cell cultures: comparison with in vitro-generated cytotoxic lymphocytes.Cell Immunol1979https://conductscience.org/library/papers/314344PubMed
4307029T cell growth factor: parameters of production and a quantitative microassay for activity.J Immunol1978https://conductscience.org/library/papers/307029PubMed
56968789Thymoma production of T cell growth factor (Interleukin 2).J Immunol1980https://conductscience.org/library/papers/6968789PubMed
66176669Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.J Exp Med1982https://conductscience.org/library/papers/6176669PubMed
76602167Induction of cytotoxic T cell function requires sequential action of three different lymphokines.J Immunol1983https://conductscience.org/library/papers/6602167PubMed
8659024In vitro generation of cytotoxicity against autologous human tumour biopsy cells.Int J Cancer1978https://conductscience.org/library/papers/659024PubMed
96984352Natural cell-mediated cytotoxicity in vitro and inhibition of tumor growth in vivo by murine lymphoid cells cultured with T cell growth factor (TCGF).Cancer Immunol Immunother1982https://conductscience.org/library/papers/6984352PubMed
106334140Suppression by tumor growth of T cell growth factor production in mouse lymphoid cell cultures.J Biol Response Mod1984https://conductscience.org/library/papers/6334140PubMed
116604229Reversible induction of natural killer cell activity in cloned murine cytotoxic T lymphocytes.Nature1983https://conductscience.org/library/papers/6604229PubMed
126224401The in vitro generation of effector lymphocytes and their employment in tumor immunotherapy.Adv Cancer Res1983https://conductscience.org/library/papers/6224401PubMed
134151339Cell-mediated cytotoxicity, allograft rejection, and tumor immunity.Adv Immunol1974https://conductscience.org/library/papers/4151339PubMed
146223084LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.J Immunol1983https://conductscience.org/library/papers/6223084PubMed
156978927Dissection of the proliferative and differentiative signals controlling murine cytotoxic T lymphocyte responses.J Exp Med1982https://conductscience.org/library/papers/6978927PubMed
166984388A rapid technique for isolation of viable tumor cells from solid tumors: use of the tumor cells for induction and measurement of cell-mediated cytotoxic responses.Eur J Cancer Clin Oncol1982https://conductscience.org/library/papers/6984388PubMed
176812964
In vitro growth of cytotoxic human lymphocytes. V. Generation of allospecific cytotoxic lymphocytes to nonimmunogenic antigen by supplementation of in vitro sensitization with partially purified T-cell growth factor.
Cell Immunol1982https://conductscience.org/library/papers/6812964PubMed
186159395Generation of cytotoxic lymphocytes to syngeneic tumor by using co-stimulator (Interleukin 2).J Immunol1980https://conductscience.org/library/papers/6159395PubMed
196444969Effects of adriamycin on the activity of mouse natural killer cells.J Immunol1980https://conductscience.org/library/papers/6444969PubMed
20147948In vitro induction of cell-mediated immunity to murine leukemia cells. III. Effect of methanol extraction residue fraction of BCG on the generation of cytotoxic lymphocytes against leukemia.J Natl Cancer Inst1978https://conductscience.org/library/papers/147948PubMed

See all 32 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.

PMIDTitleJournalYearIn PapersSource
22358536Induction of auto-logous human cytotoxic T lymphocytes (CTL) from peripheral blood against tumor cells.Cytotechnology1997https://conductscience.org/library/papers/22358536PubMed
10391094Reduction of end-stage malignant glioma by injection with autologous cytotoxic T lymphocytes.Jpn J Cancer Res1999https://conductscience.org/library/papers/10391094PubMed
3499983Lysis of fresh murine mammary tumor cells by syngeneic natural killer cells and lymphokine-activated killer cells.Cancer Immunol Immunother1987https://conductscience.org/library/papers/3499983PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6239683

GET https://conductscience.org/api/papers/v1/6239683/references?page=2